日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HLA-Shuttle: A system for enhancing antigen presentation in immunologically cold tumors.

HLA-Shuttle:一种增强免疫冷肿瘤中抗原呈递的系统。

Hwang Daniel, Erdman Molly C, Adhikari Santosh, Pantula Ram, Epstein Kaya, Li Peiyao, Costabile Francesca, Rotsides Photis, Wang Chloe S, Sun Shirley M, Fazelinia Hossein, Spruce Lynn A, Fugmann Tim, Rrustemi Trendelina, Soh Wai Tuck, Farrel Alvin, Want Muzamil Y, Facciabene Andrea, Mir Mustafa, Maris John M, Sgourakis Nikolaos G

Gut-targeted strategies at the intersection of radiotherapy and immunotherapy

放射疗法和免疫疗法交叉领域的肠道靶向策略

Facciabene, Andrea; Ellsworth, Susannah G

Tumor-to-endothelium mitochondrial transfer licenses endothelial cells for CD8(+) T cell recognition via mitochondrial neoantigen presentation.

肿瘤细胞向内皮细胞的线粒体转移通过线粒体新抗原呈递,使内皮细胞能够被 CD8(+) T 细胞识别。

Costabile Francesca, Stefano Pierini, Perales-Linares Renzo, Leli Nektaria, Bear Adham, Koch Cameron J, Carreno Beatriz M, Lotze Michael, Singh Lerry, Falck Marny, Facciabene Andrea

Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study

利用肠道靶向抗生素和立体定向放射治疗改善无法手术的早期非小细胞肺癌患者的预后:一项随机试点研究的结果

Feigenberg, Steven Joel; Costabile, Francesca; Tanes, Ceylan; Bittinger, Kyle; O'Connor, Roderick; Agarwal, Divyansh; Skoufos, Giorgos; Salaris, Silavano; Hatzigeorgiou, Artemis; Kostopoulos, Nektarios; Lloyd, Shane; Friedes, Cole; Chen, Lisha; Yegya-Raman, Nikhil; Cengel, Keith; Levin, William; Valentić, Bakir; Quarton, Tyler; Shestov, Alexander A; Berman, Abigail; Bradley, Jeffrey; Maity, Amit; Koumenis, Costantinos; Ben-Josef, Edgar; Facciabene, Andrea

An early-stage 3D fibroblast-featured tumor model mimics the gene expression of the naïve tumor microenvironment, including genes involved in cancer progression and drug resistance

一种早期三维成纤维细胞肿瘤模型能够模拟原始肿瘤微环境的基因表达,包括参与癌症进展和耐药性的基因。

Costabile, Francesca; George, Subin; Facciabene, Andrea; Filaci, Gilberto; Mastrogiacomo, Maddalena

Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

作者更正:抗CD19 CAR T细胞疗法后肠道微生物群与疗效和毒性的相关性

Smith, Melody; Dai, Anqi; Ghilardi, Guido; Amelsberg, Kimberly V; Devlin, Sean M; Pajarillo, Raymone; Slingerland, John B; Beghi, Silvia; Herrera, Pamela S; Giardina, Paul; Clurman, Annelie; Dwomoh, Emmanuel; Armijo, Gabriel; Gomes, Antonio L C; Littmann, Eric R; Schluter, Jonas; Fontana, Emily; Taur, Ying; Park, Jae H; Palomba, Maria Lia; Halton, Elizabeth; Ruiz, Josel; Jain, Tania; Pennisi, Martina; Afuye, Aishat Olaide; Perales, Miguel-Angel; Freyer, Craig W; Garfall, Alfred; Gier, Shannon; Nasta, Sunita; Landsburg, Daniel; Gerson, James; Svoboda, Jakub; Cross, Justin; Chong, Elise A; Giralt, Sergio; Gill, Saar I; Riviere, Isabelle; Porter, David L; Schuster, Stephen J; Sadelain, Michel; Frey, Noelle; Brentjens, Renier J; June, Carl H; Pamer, Eric G; Peled, Jonathan U; Facciabene, Andrea; van den Brink, Marcel R M; Ruella, Marco

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

肠道微生物群与抗CD19 CAR T细胞疗法后的反应和毒性的相关性

Smith, Melody; Dai, Anqi; Ghilardi, Guido; Amelsberg, Kimberly V; Devlin, Sean M; Pajarillo, Raymone; Slingerland, John B; Beghi, Silvia; Herrera, Pamela S; Giardina, Paul; Clurman, Annelie; Dwomoh, Emmanuel; Armijo, Gabriel; Gomes, Antonio L C; Littmann, Eric R; Schluter, Jonas; Fontana, Emily; Taur, Ying; Park, Jae H; Palomba, Maria Lia; Halton, Elizabeth; Ruiz, Josel; Jain, Tania; Pennisi, Martina; Afuye, Aishat Olaide; Perales, Miguel-Angel; Freyer, Craig W; Garfall, Alfred; Gier, Shannon; Nasta, Sunita; Landsburg, Daniel; Gerson, James; Svoboda, Jakub; Cross, Justin; Chong, Elise A; Giralt, Sergio; Gill, Saar I; Riviere, Isabelle; Porter, David L; Schuster, Stephen J; Sadelain, Michel; Frey, Noelle; Brentjens, Renier J; June, Carl H; Pamer, Eric G; Peled, Jonathan U; Facciabene, Andrea; van den Brink, Marcel R M; Ruella, Marco

Moderate Colitis Not Requiring Intravenous Steroids Is Associated with Improved Survival in Stage IV Melanoma after Anti-CTLA4 Monotherapy, But Not Combination Therapy

对于接受抗CTLA4单药治疗的IV期黑色素瘤患者,无需静脉注射类固醇的中度结肠炎与生存期延长相关,但联合治疗则无此关联。

Anstadt, Emily J; Chu, Brian; Yegya-Raman, Nikhil; Han, Xiaoyan; Doucette, Abigail; Poirier, Kendra; Mohiuddin, Jahan J; Maity, Amit; Facciabene, Andrea; Amaravadi, Ravi K; Karakousis, Giorgos C; Cohen, Justine V; Mitchell, Tara C; Schuchter, Lynn M; Lukens, John N

Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression

血管靶向治疗、低分割放射治疗和免疫检查点抑制剂联合应用可诱导强效的抗肿瘤免疫反应并阻断肿瘤进展。

Stefano Pierini ,Abhishek Mishra ,Renzo Perales-Linares ,Mireia Uribe-Herranz ,Silvia Beghi ,Andrea Giglio ,Sergei Pustylnikov ,Francesca Costabile ,Stavros Rafail ,Augusto Amici ,John G Facciponte ,Costantinos Koumenis ,Andrea Facciabene

Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression

血管靶向治疗、低分割放射治疗和免疫检查点抑制剂联合应用可诱导强效的抗肿瘤免疫反应并阻断肿瘤进展。

Stefano Pierini,Abhishek Mishra,Renzo Perales-Linares,Mireia Uribe-Herranz,Silvia Beghi,Andrea Giglio,Sergei Pustylnikov,Francesca Costabile,Stavros Rafail,Augusto Amici,John G Facciponte,Costantinos Koumenis,Andrea Facciabene